ML Ballinger, N Osman, K Hashimura, JB de … - Journal of Cellular and Molecular Medicine, 2009 - interscience.wiley.com 1 Diabetes & Cell Biology, BakerIDI Heart & Diabetes Institute, Prahran,
Australia , 2 Department of Immunology, Monash University, Melbourne, Australia
and 3 Department of Medicine, Monash University, Melbourne, Australia , 4 ... Related articles - All 2 versions
RR Ji, H de Silva, Y Jin, RE Bruccoleri, J …, 2009 - pubmedcentral.nih.gov The dose response curve is the gold standard for measuring the effect of a drug
treatment, but is rarely used in genomic scale transcriptional profiling due to
perceived obstacles of cost and analysis. One barrier to examining ... Related articles - All 4 versions
S Mariani, L Tornaghi, M Sassone, S Basciani, … - Leukemia Research, 2009 - Elsevier Imatinib inhibits the tyrosine kinase functions of BCR-ABL, platelet-derived
growth factor receptor, and c-kit receptor associated with specific diseases,
and is a first-line treatment in patients with chronic myeloid leukaemia ... Related articles - All 2 versions